Company: NCL
Filing Date: 2025-10-24
Form Type: S-1/A
Source: 0001575872-25-000638
Chunk: 60

Company: Northann Corp.
Filing Date: 2025-10-24
Form: S-1/A
Chunk 60
---
 criteria for the continued listing of particular securities, or suspend or delist particular
securities based on any event, condition, or circumstance that exists or occurs that makes continued listing of the securities on NYSE
American inadvisable or unwarranted in the opinion of NYSE American, even though the securities meet all enumerated criteria for continued
listing on NYSE American. In addition, NYSE American has used its discretion to deny continued listing or to apply additional and more
stringent criteria in the instances, including but not limited to: where the company engaged an auditor that has not been subject to an
inspection by the PCAOB, an auditor that PCAOB cannot inspect, or an auditor that has not demonstrated sufficient resources, geographic
reach, or experience to adequately perform the company’s audit. Our public offering will be relatively small and the insiders of
our Company will hold a large portion of the company’s listed securities. NYSE American might apply additional and more stringent
criteria for our initial and continued listing, which might cause a delay or even denial of our listing application.

| 25 |

Anti-takeover provisions in our charter documents and Nevada law could discourage, delay or prevent a change in control of our company and may affect the trading price of our common stock.

We are a Nevada corporation and the anti-takeover provisions
of the Nevada Revised Statutes may have the effect of deterring unsolicited takeovers or delaying or preventing a change in
control of our company or changes in our management, including transactions in which our stockholders might otherwise receive a premium
for their shares over then current market prices. In addition, these provisions may limit the ability of stockholders to approve transactions
that they may deem to be in their best interests. These provisions include:

| · | the inability of stockholders holding less than a majority of the voting 
 shares outstanding to call special meetings;                             |

| · | the “business combinations” and “control share acquisitions” provisions of Nevada                                                           
 law, to the extent applicable, could discourage attempts to acquire our stockholders stock even on terms above the prevailing market price; 
 and                                                                                                                                         |

| · | the ability of our board of directors to designate the terms of and issue new series of preferred stock                                
 without stockholder approval, which could include the right to approve an acquisition or other change in our control or could be used  
 to institute a rights plan, also known as a poison pill, that would dilute the stock ownership of a potential hostile acquirer, likely